September

Proposed Amendment: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (PDF) (September 17, 2024)

George D. Gowder, III, M.D.; Decision and Order (PDF) (September 17, 2024)

Chemtos, LLC (PDF) (September 17, 2024)

Eli-Elsohly Laboratories (PDF) (September 17, 2024)

Mary A. Vreeke, M.D.; Decision and Order (PDF) (September 16, 2024)

Awesome Care Pharmacy, Inc.; Decision and Order (PDF) (September 16, 2024)

Purisys, LLC (PDF) (September 16, 2024)

Bright Green Corporation (PDF) (September 6, 2024)

Biopharmaceutical Research Company (PDF) (September 6, 2024)

Cambridge Isotope Laboratories, Inc. (PDF) (September 6, 2024)

Final Order: Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2024 (PDF) (September 5, 2024)

Samirkumar Shah, M.D.; Decision and Order (PDF) (September 4, 2024)

Chattem Chemicals (PDF) (September 4, 2024)

Bright Green Corporation (PDF) (September 4, 2024)

Continuus Pharmaceuticals (PDF) (September 4, 2024)

Catalent CTS, LLC (PDF) (September 4, 2024)

Benuvia Operations, LLC (PDF) (September 4, 2024)

Indivior Inc. (PDF) (September 4, 2024)

Amneal Complex Products Research LLC (PDF) (September 4, 2024)

Chattem Chemicals, Inc. (PDF) (September 4, 2024)

Biopharmaceutical Research Company (PDF) (September 4, 2024)

Cambridge Isotope Laboratories, Inc. (PDF) (September 4, 2024)

Fisher Clinical Services, Inc. (PDF) (September 4, 2024)

Caligor Coghlan Pharma Services (PDF) (September 4, 2024)

Cambrex High Point, Inc (PDF) (September 4, 2024)

Stephen McCarthy, P.A.; Decision and Order (PDF) (September 3, 2024)

 

  • REGISTRATION
  • REPORTING
  • RESOURCES
  • CONTACT US
  • PRIVACY NOTICE
  • GET EMAIL UPDATES